Halifax Health has expanded its Hyperbaric Medicine Program with the addition of a new Hyperbaric Oxygen Therapy (HBOT) suite. The expansion includes three new HBOT chambers, bringing the total to six, positioning Halifax Health as a leading provider of hyperbaric treatment in the region.

This expansion allows Halifax Health to offer a broader range of HBOT treatments for various complex conditions beyond traditional wound care. Hyperbaric Oxygen Therapy involves breathing pure oxygen in a pressurized chamber, enhancing oxygen absorption and promoting healing. The program now treats conditions such as non-healing wounds, diabetes-related wounds, radiation injury and bone infections, as well as exploring potential treatments for traumatic brain injury, PTSD, long COVID, autism, chronic pain, chronic Lyme disease, post-stroke recovery and certain types of hearing and vision loss.

The Advanced Wound Healing & Hyperbaric Medicine team at Halifax Health is led by Dr. Steven Levine, Dr. Scott Covington and Dr. Paul Johnson. Johnson, a fellowship-trained hyperbaric physician from LSU, brings extensive expertise in HBOT, enabling the team to provide personalized and comprehensive treatment plans.

Halifax Health’s new HBOT suite enhances its capacity to treat more patients and underscores its commitment to pioneering medical care. With this expansion, Halifax Health continues to explore the full potential of HBOT in improving patient outcomes.